Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether thorough analytical evaluation is useful to diagnose metabolic conditions associated to calcium pyrophosphate deposition disease.


Clinical Trial Description

The diagnostic usefulness of screening for hyperparathyroidism, hemochromatosis, hypothyroidism and hypophosphatasia in patients diagnosed with calcium pyrophosphate dihydrate (CPPD) deposition disease is uncertain.

Patients diagnosed with CPPD deposition disease were compared to patients with rheumatoid arthritis and psoriatic arthritis over a 9-year period. All patients were prospectively followed for at least 12 months. Serum calcium, phosphorus, alkaline phosphatase, thyroid-stimulating hormone, ferritin, iron, and total iron binding capacity were determined in all patients. ;


Study Design

Observational Model: Case Control, Time Perspective: Longitudinal


Related Conditions & MeSH terms


NCT number NCT00453128
Study type Observational
Source Sociedade Galega de Reumatoloxía
Contact
Status Completed
Phase N/A
Start date January 1997
Completion date December 2006

See also
  Status Clinical Trial Phase
Recruiting NCT01867840 - Role of ASICs in Human Inflammatory Pain N/A
Completed NCT00797537 - Ultrasound and X-ray in Detecting Articular Cartilage Calcification N/A
Recruiting NCT04695028 - CRYSTALILLE Cohort: Getting the Whole Picture of Crystal-related Arthropathies
Recruiting NCT01642706 - Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments
Completed NCT03128905 - Trial of Colchicine Versus Prednisone for the Treatment of Acute CPPD Arthritis Phase 3